Geode Capital Management
ASXC

Geode Capital Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Geode Capital Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,498,153
Closed -$832K – 4620
2024
Q2 		$832K Buy
2,498,153
+98,724
+4% +$26.6K ﹤0.01% 3380
2024
Q1 		$552K Hold
2,399,429
– – ﹤0.01% 3575
2023
Q4 		$765K Buy
2,399,429
+117,365
+5% +$30.3K ﹤0.01% 3450
2023
Q3 		$616K Buy
2,282,064
+173,942
+8% +$63.2K ﹤0.01% 3525
2023
Q2 		$1.06M Sell
2,108,122
-159,259
-7% -$95.2K ﹤0.01% 3325
2023
Q1 		$1.49M Buy
2,267,381
+80,678
+4% +$54.6K ﹤0.01% 3154
2022
Q4 		$759K Sell
2,186,703
-5,068
-0.2% -$2.06K ﹤0.01% 3487
2022
Q3 		$983K Buy
2,191,771
+4,666
+0.2% +$2.43K ﹤0.01% 3399
2022
Q2 		$870K Sell
2,187,105
-1,537,226
-41% -$686K ﹤0.01% 3492
2022
Q1 		$2.33M Sell
3,724,331
-112,273
-3% -$86.5K ﹤0.01% 3179
2021
Q4 		$4.26M Sell
3,836,604
-61,663
-2% -$95.3K ﹤0.01% 2986
2021
Q3 		$7.21M Buy
3,898,267
+114,499
+3% +$257K ﹤0.01% 2697
2021
Q2 		$12M Buy
3,783,768
+2,755,703
+268% +$6.89M ﹤0.01% 2333
2021
Q1 		$3.34M Buy
1,028,065
+663,776
+182% +$2.4M ﹤0.01% 2982
2020
Q4 		$227K Buy
364,289
+257,118
+240% +$118K ﹤0.01% 3850
2020
Q3 		$37K Sell
107,171
-27,743
-21% -$10.7K ﹤0.01% 4061
2020
Q2 		$72K Sell
134,914
-205,974
-60% -$99.4K ﹤0.01% 3925
2020
Q1 		$119K Buy
340,888
+155,287
+84% +$162K ﹤0.01% 3712
2019
Q4 		$272K Buy
185,601
+5,947
+3% +$20.7K ﹤0.01% 3705
2019
Q3 		$1.45M Buy
179,654
+2,578
+1% +$35.1K ﹤0.01% 3093
2019
Q2 		$3.13M Buy
177,076
+17,687
+11% +$387K ﹤0.01% 2668
2019
Q1 		$4.93M Buy
159,389
+19,251
+14% +$645K ﹤0.01% 2345
2018
Q4 		$4.12M Buy
140,138
+9,815
+8% +$446K ﹤0.01% 2333
2018
Q3 		$9.83M Buy
130,323
+41,258
+46% +$2.79M ﹤0.01% 1933
2018
Q2 		$5.05M Buy
89,065
+37,514
+73% +$1.37M ﹤0.01% 2317
2018
Q1 		$1.14M Hold
51,551
– – ﹤0.01% 3060
2017
Q4 		$1.29M Hold
51,551
– – ﹤0.01% 2990
2017
Q3 		$958K Buy
51,551
+21,280
+70% +$248K ﹤0.01% 3140
2017
Q2 		$279K Sell
30,271
-8,659
-22% -$82.4K ﹤0.01% 3571
2017
Q1 		$612K Buy
38,930
+1,195
+3% +$20.7K ﹤0.01% 3234
2016
Q4 		$637K Buy
37,735
+868
+2% +$17.8K ﹤0.01% 3187
2016
Q3 		$809K Buy
36,867
+1,077
+3% +$19.7K ﹤0.01% 3058
2016
Q2 		$567K Buy
35,790
+6,007
+20% +$189K ﹤0.01% 3173
2016
Q1 		$1.65K Buy
29,783
+5,536
+23% +$237K ﹤0.01% 2587
2015
Q4 		$781K Buy
24,247
+171
+0.7% +$5.51K ﹤0.01% 3044
2015
Q3 		$707K Buy
24,076
+639
+3% +$23.7K ﹤0.01% 3062
2015
Q2 		$913K Buy
23,437
+8,525
+57% +$393K ﹤0.01% 2948
2015
Q1 		$568K Buy
14,912
+187
+1% +$7.05K ﹤0.01% 3143
2014
Q4 		$557K Hold
14,725
– – ﹤0.01% 3138
2014
Q3 		$834K Buy
14,725
+919
+7% +$49.5K ﹤0.01% 2889
2014
Q2 		$904K Buy
+13,806
New +$797K ﹤0.01% 2860

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Geode Capital Management's ASXC Position: Q3 2024 in Review

Geode Capital Management sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 2,498,153 shares — an estimated $832K sold.

Geode Capital Management first reported a position in ASXC in Q2 2014 and held it in 41 quarters. The position peaked at $12M in Q2 2021. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Geode Capital Management reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Geode Capital Management sold 2,498,153 Asensus Surgical, Inc. shares in Q3 2024, an estimated $832K.
  • Geode Capital Management first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 41 quarters.
  • Geode Capital Management's Asensus Surgical, Inc. position peaked at $12M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.